Clinical Spectrum of Hermansky–Pudlak Syndrome

Anastasia M. Bobreshova,Sofya A. Ionova,Vitaly V. Kadyshev,Natella V. Sukhanova,Iuliia V. Viakhireva,Alexandra Yu. Filatova,Natalia V. Zhurkova,Peter A. Sparber,Andrey V. Marakhonov,Tatyana A. Vasilyeva,Olga A. Shchagina,Sergey I. Kutsev,Rena A. Zinchenko
DOI: https://doi.org/10.3390/ijms252011260
IF: 5.6
2024-10-20
International Journal of Molecular Sciences
Abstract:Hermansky–Pudlak syndrome (HPS) is a rare disease inherited in the autosomal recessive mode, including 11 clinical genetic subtypes. They are associated with impaired function of the BLOC protein complex (Biogenesis of Lysosome-related Organelles Complexes), and the subunits of the AP-3 complex (adaptor protein complex). Each has its own clinical features, but they are all characterized by albinism, bleeding disorder, and visual abnormalities. Eleven patients from eight unrelated families with an incoming diagnosis of albinism were examined and novel and previously described genetic variants in HPS1, HPS6, and BLOC1S6 genes (types HPS1, HPS6, and HPS9) were found. To determine the optimal therapy and recommendations for further follow up, it is necessary to consider the entire clinical spectrum and genetic polymorphism of the disease. An interdisciplinary approach, combined with the use of non-routine diagnostic techniques such as RNA analysis, is essential for achieving accurate diagnoses in certain complex cases.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?